What's With Wall Street's Lofty Price Targets On Intercept?
February 10, 2017 at 14:57 PM EST
Intercept Pharmaceuticals Inc (NASDAQ: ICPT) maintains an average price target of $203 — a 68.9-percent upside from the present ...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.